glp 1 celebrities before and after Who've Said They're On Ozempic, Weight-Loss Drugs celebrities on glp-1 before and

Furthermore, following the 2008 US Food and Drug Administration (FDA) guidance for industry that requires proof of cardiovascular safety as a prerequisite for approval of diabetes treatments, there has been a substantial increase in the understanding of the risks of these treatments, in addition to their benefits, on clinically relevant outcomes

Regarding weight loss, the FDA has approved these drugs for people whose body mass index (BMI) is greater than 30 kg/m2, or they have a BMI that is greater than 27 and have a weight-related health problem, such as high blood pressure, sleep apnea, or pre-diabetes

Also, these medications should be used with caution in individuals with a history of pancreatitis or thyroid C-cell tumors due to a potential increased risk associated with these conditions

Frequent monitoring by the healthcare provider is recommended